XML 16 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues    
Product revenue, net $ 95,556 $ 105,650
Collaboration revenue 4,055 837
Total revenues 99,611 106,487
Expenses    
Cost of product revenue (38,315) (38,452)
Cost of collaboration revenue (20) (195)
Research and development (65,591) (60,729)
Selling, general, and administrative (65,070) (63,422)
Loss from operations (69,385) (56,311)
Interest income 6,447 8,606
Interest expenses (1,637) (1,187)
Foreign currency gains 14,837 651
Other income (expense), net 162 (197)
Loss before income tax (49,576) (48,438)
Income tax expense (1,440) 0
Net loss $ (51,016) $ (48,438)
Loss per share - basic (in dollars per share) $ (0.05) $ (0.04)
Loss per share - diluted (in dollars per share) $ (0.05) $ (0.04)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares) 1,107,390,590 1,080,825,300
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares) 1,107,390,590 1,080,825,300